๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Diabetes
Clinical trial register · China

Diabetes Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 10 Linyi 4 Shenyang 3 Changsha 3 Nanjing 3
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai10 Linyi4 Shenyang3 Changsha3 Nanjing3
All 29 locations
Target enrolment
to

Diabetes trials in China

29 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Rowing and Cycling Reduce Inflammation in Early-Stage Type 2 Diabetes
NCT07769840Diabetes
The 95th Hospital of Putian๏ผŒPutian, Fujian, China
Not applicable
120
Putian
2026-10-01
Not yet open
Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes
NCT07557914HCC - Hepatocellular Carcinoma, Diabetes
Haibo Shao
Phase 2
32
Shenyang
2026-10
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Active, closed
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NCT07350486Hypertension, Diabetes, Dyslipidemia
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Recruiting
Auricular Acupuncture Therapy Administered by Village Doctors Improves Sleep Quality in Elderly Patients With Comorbid Diabetes Mellitus and Hypertension
NCT07554235Insomnia Disorder, Diabetes, Hypertension
Jiangsu Taizhou People's Hospital
Not applicable
320
Taizhou
2026-04-22
Active, closed
A Study of SYH2069 Injection in Healthy Participants
NCT07736391Overweight or Obesity, Diabetes
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1
104
Nanjing
2026-01-10
Recruiting
Raman Spectroscopy-Based Non-Invasive Blood Glucose Detection
NCT07311421Diabetes
Beijing Shijitan Hospital, Capital Medical University
Observational
49
Beijing, Haidian
2026-01-01
Active, closed
Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
NCT07193147Diabetes
Gan & Lee Pharmaceuticals.
Phase 1
36
Linyi
2025-10-20
Not yet open
Observational Analysis of the Associational Between Dietary Factors and Postprandial Glucose Fluctuations
NCT07117188Diabetes
Shanghai Zhongshan Hospital
Observational
48
Shanghai
2025-08-05
Recruiting
Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients
NCT07077538Peritoneal Dialysis, Diabetes
The People's Hospital of Gaozhou
Not applicable
70
Gaozhou
2025-07-30
Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
NCT07043166Metabolic Syndrome, Diabetes, Obesity and Overweight, Hypertension
Shanghai Changzheng Hospital
Observational
4,094
Shanghai
2025-07-01
Recruiting
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513Hypertension, Diabetes, Atrial Fibrillation, Dyslipidemia
Affiliated Hospital of Nantong University
Not applicable
300
Nantong
2025-04-20
Not yet open
Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes
NCT06847178Diabetes, Type 2 Diabetes
Shanghai Changzheng Hospital
Phase 2/3
60
Shanghai
2025-03-01
Active, closed
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT06767735Diabetes
Gan & Lee Pharmaceuticals.
Phase 3
580
Linyi
2025-02-17
Recruiting
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
NCT06821399Diabetes, Diabetic Retinopathy, Type 2 Diabetes Mellitus (T2DM)
Yufan Wang
Observational
2,920
Lanzhou, Shanghai, Shenyang
2025-02-01
Not yet open
Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
NCT06777810Diabetic Foot Disease, Diabetic Foot Ulcer, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-01-31
Recruiting
UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes
NCT06751199Diabetes
Shanghai Changzheng Hospital
Not applicable
16
Shanghai
2024-12-30
Active, closed
Predictive Analysis of Diabetic Foot Ulcer
NCT06768554Diabetic Foot Ulcer (DFU), Diabetic Foot Disease, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
2,000
Shanghai
2024-10-31
Not yet open
PK and PD of YG1699 in CKD Patients With Diabetes
NCT06648876Diabetes, Renal Insufficiency, Chronic, Hemodialysis
RenJi Hospital
Phase 1
20
Shanghai
2024-10-31
Recruiting
IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus
NCT06380868Diabetes
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,332
Nanjing
2024-07-17
Recruiting
Predictive Effect of TGF-ฮฒ and INS-PI3K-AKT Related Proteins for POD in Diabetes Patients
NCT06426953Diabetes, Postoperative Delirium
Xie Kangjie
Observational
180
Duyun, Hangzhou
2024-05-20
Recruiting
Precision Medicine of Diabetes Program in China
NCT06320600Diabetes
Second Xiangya Hospital of Central South University
Observational
120,000
Changsha
2023-07-01
Recruiting
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
NCT05498974Type1diabetes, Diabetes
Second Xiangya Hospital of Central South University
Observational
20,000
Lanzhou, Shenzhen, Haikou, Harbin, Luoyang, Changsha, Nanjing, Changzhi
2022-01-01
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
NCT04743479Pancreatic Cancer, Diabetes, Familial Pancreatic Cancer, Pancreatic Cystic Neoplasm
Changhai Hospital
Observational
5,000
Shanghai
2020-12-01
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/diabetes

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies listing the condition Diabetes.

How many Diabetes trials are recruiting in China?

16 of the 29 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Diabetes), 29 studies
PhaseStudiesRecruitingShare
Observational10734.5%
Not applicable9731%
Phase 34113.8%
Phase 13010.3%
Phase 2216.9%
Phase 2/3103.4%

Most active sponsors

Lead sponsors with the most studies (Diabetes)
Lead sponsorStudiesRecruiting
Gan & Lee Pharmaceuticals.51
Shanghai Changzheng Hospital32
Second Xiangya Hospital of Central South University22
Shanghai Jiao Tong University School of Medicine20
Affiliated Hospital of Nantong University11
Beijing Shijitan Hospital, Capital Medical University11
Changhai Hospital11
China Medical University, China11
CSPC Ouyi Pharmaceutical Co., Ltd.10
First Hospital of China Medical University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.